AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Laviceftra S 125mg/62.5mg Injection

Prescription Icon
Prescription Required

Marketer

Lavish Biotech

Salt Composition

Ceftriaxone (125mg) + Sulbactam (62.5mg)

Overview Laviceftra S 125mg/62.5mg Injection

Combiflora-S 125mg/62.5mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be overseen by a medical professional. Consistent adherence to the prescribed dosage schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate medical assistance for allergic reactions (e.g., rashes, pruritus, edema, dyspnea). Inform your physician of all concurrent medications before initiating treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and sufficient hydration are recommended for optimal recovery. Your doctor might order blood tests and other examinations to monitor treatment response.

Uses of Laviceftra S 125mg/62.5mg Injection

Infections caused by bacteria

Major Benefits of Laviceftra S 125mg/62.5mg Injection:

This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.

Common Side effects of Laviceftra S 125mg/62.5mg Injection:

  • Increased white blood cell count (eosinophils)
  • Decreased white blood cell count (lymphocytes)
  • Low blood platelets
  • Rash
  • Diarrhea
  • Increased liver enzymes
  • Injection site reactions (pain, swelling, redness)

How to use Laviceftra S 125mg/62.5mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Laviceftra S 125mg/62.5mg Injection works:

Ceftriaxone/Sulbactam injection (Laviceftra S 125mg/62.5mg) combines the antibiotic ceftriaxone with the beta-lactamase inhibitor sulbactam. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, compromising their survival. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting ceftriaxone's effectiveness.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions associated with concomitant use of Laviceftra S 125mg/62.5mg Injection and alcohol.

PregnancyPregnancySAFE IF PRESCRIBED

The injectable medication Laviceftra S (125mg/62.5mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies are scarce.

Breast feedingBreast feedingCAUTION

Administering Laviceftra S 125mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.

DrivingDrivingUNSAFE

Administering Laviceftra S 125mg/62.5mg Injection can lead to drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding Laviceftra S 125mg/62.5mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should use Laviceftra S 125mg/62.5mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Laviceftra S 125mg/62.5mg Injection is unnecessary in individuals with mild to moderate liver dysfunction.

What if you forget to take Laviceftra S 125mg/62.5mg Injection :

Omitting a scheduled dose of Laviceftra S 125mg/62.5mg Injection warrants immediate physician consultation.

Facts to Know About Laviceftra S 125mg/62.5mg Injection

LabelValue
Developing Habits No.
Treatment Category Antimicrobials

FAQs on Laviceftra S 125mg/62.5mg Injection

Laviceftra S 125mg/62.5mg Injection may trigger allergic reactions and is contraindicated for individuals with known cephalosporin allergies. Seek immediate medical attention if you experience allergic symptoms such as hives, breathing difficulties, or swelling of the face, lips, tongue, or throat.
Laviceftra S 125mg/62.5mg Injection can cause diarrhea as a side effect. This is because, while it eliminates harmful bacteria, it can also disrupt beneficial gut bacteria. Consult your doctor if you experience severe diarrhea.
Laviceftra S 125mg/62.5mg Injection typically begins working quickly, although complete bacterial eradication and symptom relief may take several days.
Contact your doctor if your symptoms worsen during treatment or persist after completing the full course.
Continue taking your Laviceftra S 125mg/62.5mg Injection as prescribed, completing the entire course. Even if you feel better, the infection may not be fully eradicated.
Laviceftra S 125mg/62.5mg...
30
MRP 37
18% off